149 related articles for article (PubMed ID: 32710273)
1. Development and Prospective Validation of a Risk Calculator That Predicts a Low Risk Cohort for Atypical Ductal Hyperplasia Upstaging to Malignancy: Evidence for a Watch and Wait Strategy of a High-Risk Lesion.
Lustig DB; Guo M; Liu C; Warburton R; Dingee CK; Pao JS; Kuusk U; Chen L; McKevitt EC
Ann Surg Oncol; 2020 Nov; 27(12):4622-4627. PubMed ID: 32710273
[TBL] [Abstract][Full Text] [Related]
2. Pure flat epithelial atypia identified on core needle biopsy does not require excision.
Liu C; Dingee CK; Warburton R; Pao JS; Kuusk U; Bazzarelli A; Sidhu R; McKevitt EC
Eur J Surg Oncol; 2020 Feb; 46(2):235-239. PubMed ID: 31685259
[TBL] [Abstract][Full Text] [Related]
3. Flat epithelial atypia on core needle biopsy does not always mandate excisional biopsy.
Srour MK; Donovan C; Chung A; Harit A; Dadmanesh F; Giuliano AE; Amersi F
Breast J; 2020 Apr; 26(4):679-684. PubMed ID: 31562689
[TBL] [Abstract][Full Text] [Related]
4. Atypical ductal hyperplasia on core biopsy: an automatic trigger for excisional biopsy?
McGhan LJ; Pockaj BA; Wasif N; Giurescu ME; McCullough AE; Gray RJ
Ann Surg Oncol; 2012 Oct; 19(10):3264-9. PubMed ID: 22878619
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy.
Chae BJ; Lee A; Song BJ; Jung SS
World J Surg Oncol; 2009 Oct; 7():77. PubMed ID: 19852801
[TBL] [Abstract][Full Text] [Related]
6. Scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia at ultrasound-guided core needle biopsy.
Ko E; Han W; Lee JW; Cho J; Kim EK; Jung SY; Kang MJ; Moon WK; Park IA; Kim SW; Kim KS; Lee ES; Min KH; Kim SW; Noh DY
Breast Cancer Res Treat; 2008 Nov; 112(1):189-95. PubMed ID: 18060577
[TBL] [Abstract][Full Text] [Related]
7. Use of Breast Magnetic Resonance Imaging in Women Diagnosed With Atypical Ductal Hyperplasia at Core Needle Biopsy Helps Select Women for Surgical Excision.
Amitai Y; Menes T; Golan O
Can Assoc Radiol J; 2018 Aug; 69(3):240-247. PubMed ID: 29958833
[TBL] [Abstract][Full Text] [Related]
8. Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasia.
Pawloski KR; Christian N; Knezevic A; Wen HY; Van Zee KJ; Morrow M; Tadros AB
Breast Cancer Res Treat; 2020 Dec; 184(3):873-880. PubMed ID: 32857242
[TBL] [Abstract][Full Text] [Related]
9. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision.
Wagoner MJ; Laronga C; Acs G
Am J Clin Pathol; 2009 Jan; 131(1):112-21. PubMed ID: 19095574
[TBL] [Abstract][Full Text] [Related]
10. Atypical ductal hyperplasia on core needle biopsy: Development of a predictive model stratifying carcinoma upgrade risk on excision.
Salagean ED; Slodkowska E; Nofech-Mozes S; Hanna W; Parra-Herran C; Lu FI
Breast J; 2019 Jan; 25(1):56-61. PubMed ID: 30461131
[TBL] [Abstract][Full Text] [Related]
11. Upstage Rate of Complex Sclerosing Lesions/Radial Scars.
Jones VM; Pearce JB; Khalil M; Cain O; Coldren D; Martin H; Howard-McNatt M; Levine E; Chiba A
Am Surg; 2022 May; 88(5):964-967. PubMed ID: 35262438
[TBL] [Abstract][Full Text] [Related]
12. Determination of Factors Associated with Upstage in Atypical Ductal Hyperplasia to Identify Low-Risk Patients Where Active Surveillance May be an Alternative.
Greene AJE; Davis J; Moon J; Dubin I; Cruz A; Gupta M; Moazzez A; Ozao-Choy J; Gupta E; Manchandia T; Kalantari BN; Rahbar G; Dauphine C
Ann Surg Oncol; 2024 May; 31(5):3177-3185. PubMed ID: 38386195
[TBL] [Abstract][Full Text] [Related]
13. The effect of delay of excisional biopsy on upstage rate for atypical ductal hyperplasia, flat epithelial atypia, intraductal papilloma, and radial scar.
Casaubon J; Niakan S; Vicks E; Perez Coulter A; Jacobbe DL; Mason H
Breast Cancer Res Treat; 2022 Dec; 196(3):527-534. PubMed ID: 36181604
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY
Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854
[TBL] [Abstract][Full Text] [Related]
15. High rate of postoperative upstaging of ductal carcinoma in situ when prioritizing ultrasound evaluation of mammography-detected lesions: a single-center retrospective cohort study.
Hsieh YC; Lo C; Lee YH; Chien N; Lu TP; Tsai LW; Wang MY; Kuo WH; Chang YC; Huang CS
World J Surg Oncol; 2023 Feb; 21(1):48. PubMed ID: 36804000
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging-guided core needle breast biopsies resulting in high-risk histopathologic findings: upstage frequency and lesion characteristics.
Weinfurtner RJ; Patel B; Laronga C; Lee MC; Falcon SL; Mooney BP; Yue B; Drukteinis JS
Clin Breast Cancer; 2015 Jun; 15(3):234-9. PubMed ID: 25579460
[TBL] [Abstract][Full Text] [Related]
17. Borderline atypical ductal hyperplasia/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively.
Vandenbussche CJ; Khouri N; Sbaity E; Tsangaris TN; Vang R; Tatsas A; Cimino-Mathews A; Argani P
Am J Surg Pathol; 2013 Jun; 37(6):913-23. PubMed ID: 23598968
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting the under-diagnosis of atypical ductal hyperplasia diagnosed by core needle biopsies - A 10-year retrospective study and review of the literature.
Co M; Kwong A; Shek T
Int J Surg; 2018 Jan; 49():27-31. PubMed ID: 29146271
[TBL] [Abstract][Full Text] [Related]
19. Radiologic and Pathologic Features Associated With Upgrade of Atypical Ductal Hyperplasia at Surgical Excision.
Williams KE; Amin A; Hill J; Walter C; Inciardi M; Gatewood J; Redick M; Wick J; Hunt S; Winblad O
Acad Radiol; 2019 Jul; 26(7):893-899. PubMed ID: 30318287
[TBL] [Abstract][Full Text] [Related]
20. Is Surgical Excision of Focal Atypical Ductal Hyperplasia Warranted? Experience at a Tertiary Care Center.
Grabenstetter A; Brennan SB; Sevilimedu V; Kuba MG; Giri DD; Wen HY; Morrow M; Brogi E
Ann Surg Oncol; 2023 Jul; 30(7):4087-4094. PubMed ID: 36905438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
